Qsemble Capital Management’s Royalty Pharma RPRX Stock Holding History

Qsemble Capital Management’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$599K	Buy	+10,675	New	+$556K	0.08%	274
2026 Q1	–	Sell	-74,416	Closed	-$2.88M	–	601
2025 Q4	$2.88M	Buy	+74,416	New	+$2.84M	0.24%	143
2025 Q3	–	Sell	-72,954	Closed	-$2.63M	–	584
2025 Q2	$2.63M	Buy	72,954 +61,255	+524%	+$2.03M	0.25%	131
2025 Q1	$364K	Sell	11,699 -168,321	-94%	-$5.34M	0.04%	340
2024 Q4	$4.59M	Buy	180,020 +140,527	+356%	+$3.73M	0.61%	43
2024 Q3	$1.12M	Buy	+39,493	New	+$1.09M	0.21%	164

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Qsemble Capital Management's RPRX Position: Q2 2026 in Review

Qsemble Capital Management opened a new position in Royalty Pharma (RPRX) in Q2 2026: 10,675 shares worth $599K. The stake represents 0.08% of the portfolio and ranks #274 among its holdings. This is a return to the name: Qsemble Capital Management previously reported a position in RPRX as recently as Q4 2025.

Qsemble Capital Management first reported a position in RPRX in Q3 2024 and has held it in 6 quarters since. The position peaked at $4.59M in Q4 2024. 645 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

Qsemble Capital Management held 10,675 shares of Royalty Pharma worth $599K as of Q2 2026.
Royalty Pharma was a new Qsemble Capital Management position in Q2 2026.
Royalty Pharma made up 0.08% of Qsemble Capital Management's portfolio in Q2 2026, its #274 holding.
Qsemble Capital Management first reported a position in Royalty Pharma in Q3 2024 and has held it in 6 quarters since.
Qsemble Capital Management's Royalty Pharma position peaked at $4.59M in Q4 2024.
645 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Qsemble Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.